Assembly Biosciences Inc <ASMB.O>: UBS Initiates Coverage With Buy Rating and Target Price $52
ASMB•Related News
GE Vernova CEO Strazik to speak at Morgan Stanley Laguna Conference
GEV•
CorMedix management to join Wells Fargo Healthcare Conference fireside chat
CRMD•
US to urge hands-off AI regulation at G20, official says
QQQ•
enGene Therapeutics to Present at Wells Fargo Healthcare Conference
ENGN•
NCS Multistage stock set to exit Nasdaq after merger completion
NCSM•